InvestorsHub Logo
Followers 145
Posts 27558
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Friday, 08/04/2017 9:04:15 AM

Friday, August 04, 2017 9:04:15 AM

Post# of 2808
BioLineRx (NASDAQ:BLRX) initiated
with Outperform rating and $3 (186% upside)
price target by Oppenheimer.
Shares up 4% premarket.

https://seekingalpha.com/news/3285958-premarket-analyst-action-healthcare?app=1&uprof=45#email_link

smile
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News